Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 113433494 | 11343349 | 4 | F | 20131125 | 20160822 | 20150806 | 20160829 | PER | PHHY2014US072247 | NOVARTIS | 50.89 | YR | F | Y | 0.00000 | 20160829 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 113433494 | 11343349 | 1 | PS | GILENYA | FINGOLIMOD HYDROCHLORIDE | 1 | Oral | 22527 | CAPSULE | ||||||||||
| 113433494 | 11343349 | 2 | C | NYSTATIN. | NYSTATIN | 1 | Topical | UNK | Y | 0 | |||||||||
| 113433494 | 11343349 | 3 | C | UBIQUINOL | UBIQUINOL | 1 | Oral | 200 MG, UNK | Y | 0 | 200 | MG | |||||||
| 113433494 | 11343349 | 4 | C | MULTI VIT | 2 | Oral | UNK UNK, DU | Y | 0 | ||||||||||
| 113433494 | 11343349 | 5 | C | HYDROCORTISONE BUTYRATE. | HYDROCORTISONE BUTYRATE | 1 | Topical | 0.1 %, QD | U | 0 | .1 | PCT | QD | ||||||
| 113433494 | 11343349 | 6 | C | GABAPENTIN. | GABAPENTIN | 1 | Unknown | 300 MG, QD | U | 0 | 300 | MG | QD | ||||||
| 113433494 | 11343349 | 7 | C | FISH OIL | FISH OIL | 1 | Unknown | 1000 MG, QD | U | 0 | |||||||||
| 113433494 | 11343349 | 8 | C | VITAMINA B 12 | 2 | Oral | 500 UG, QD | U | 0 | 500 | UG | QD | |||||||
| 113433494 | 11343349 | 9 | C | COENZYME Q10 | UBIDECARENONE | 1 | Oral | 30 MG, QD | U | 0 | 30 | MG | QD | ||||||
| 113433494 | 11343349 | 10 | C | VITAMIN D | CHOLECALCIFEROL | 1 | Oral | 2000 IU, QD | U | 0 | 2000 | IU | QD | ||||||
| 113433494 | 11343349 | 11 | C | ALOE VERA | ALOE VERA LEAF | 1 | Oral | 470 MG, QD | U | 0 | 470 | MG | QD | ||||||
| 113433494 | 11343349 | 12 | C | COCONUT OIL | COCONUT OIL | 1 | Oral | 1000 MG, QD | U | 0 | 1000 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 113433494 | 11343349 | 1 | Multiple sclerosis |
| 113433494 | 11343349 | 2 | Tinea pedis |
| 113433494 | 11343349 | 3 | Routine health maintenance |
| 113433494 | 11343349 | 4 | Routine health maintenance |
| 113433494 | 11343349 | 5 | Rash |
| 113433494 | 11343349 | 6 | Nystagmus |
| 113433494 | 11343349 | 7 | Routine health maintenance |
| 113433494 | 11343349 | 8 | Routine health maintenance |
| 113433494 | 11343349 | 9 | Routine health maintenance |
| 113433494 | 11343349 | 10 | Vitamin D deficiency |
| 113433494 | 11343349 | 11 | Routine health maintenance |
| 113433494 | 11343349 | 12 | Routine health maintenance |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 113433494 | 11343349 | Lymphocyte count decreased | |
| 113433494 | 11343349 | White blood cell count decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 113433494 | 11343349 | 2 | 20130930 | 201403 | 0 | |
| 113433494 | 11343349 | 3 | 20130808 | 20140224 | 0 | |
| 113433494 | 11343349 | 4 | 20130808 | 20140707 | 0 | |
| 113433494 | 11343349 | 5 | 20130808 | 0 | ||
| 113433494 | 11343349 | 6 | 20120410 | 0 | ||
| 113433494 | 11343349 | 7 | 20130808 | 0 | ||
| 113433494 | 11343349 | 8 | 20120810 | 0 | ||
| 113433494 | 11343349 | 9 | 20110822 | 0 | ||
| 113433494 | 11343349 | 10 | 20110422 | 0 | ||
| 113433494 | 11343349 | 11 | 20130808 | 0 | ||
| 113433494 | 11343349 | 12 | 20130805 | 0 |